![Boundless Bio Inc](/common/images/company/N_BOLD.png)
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Return on Assets (%) | -76.114 |
Return on Equity (%) | 77.799 |
Return on Invested Capital (%) | -91.388 |
Operating Margin (%) | N/A |
Net Profit Margin (%) | N/A |
Book Value Per Share | 0.387 |
Earnings Per Share | -0.159 |
Cash Per Share | 0.076 |
Working Capital Per Share | 0.368 |
Operating Profit Per Share | N/A |
EBIT Per Share | -0.159 |
EBITDA Per Share | -0.159 |
Free Cash Flow Per Share | -0.16 |
Year End December 30 2023 | 2023 |
---|---|
Current Ratio | 13.271 |
Quick Ratio | 12.902 |
Inventory Turnover (Days) | N/A |
Shares Outstanding | 311.79M |
Year End December 30 2023 | Mar 2024 |
---|---|
USD ($) | |
Shares Outstanding | N/A |
Return on Assets (%) | N/A |
Return on Equity (%) | N/A |
Return on Invested Capital (%) | N/A |
Operating Margin (%) | N/A |
Net Profit Margin (%) | N/A |
Sales Per Share | N/A |
Book Value Per Share | N/A |
Earnings Per Share | N/A |
Cash Per Share | N/A |
Working Capital Per Share | N/A |
Operating Profit Per Share | N/A |
EBIT Per Share | N/A |
EBITDA Per Share | N/A |
Free Cash Flow Per Share | N/A |
Current Ratio | 10.537 |
Quick Ratio | 9.853 |
Inventory Turnover (Days) | N/A |
Market Cap | 93.47M |
Price to Earnings Ratio | -1.84 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.83 |
Price to Book Ratio | 0.75 |
Dividend Yield | - |
Shares Outstanding | 22.25M |
Average Volume (1 week) | 48.04k |
Average Volume (1 Month) | 140.4k |
52 Week Change | -71.37% |
52 Week High | 15.20 |
52 Week Low | 3.75 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.